Trial reportScientific reports2025
Effect of an educational intervention using the extended parallel process model on preventive lifestyle for metabolic syndrome among Iranian employees.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the prevalence of Metabolic Syndrome (MetS) among employees and the role of lifestyle in its prevention, this study examined the effect of an educational intervention based on the Extended Parallel Process Model (EPPM) to promote a preventive lifestyle for MetS among Iranian employees. This parallel-group randomized clinical trial was conducted at Rafsanjan University of Medical Sciences in Iran from 2022 to 2023. A total of 144 employees without MetS were randomly assigned to either the intervention group (n = 72) or the control group (n = 72). Data were collected using two instruments to assess the EPPM variables and preventive lifestyle for MetS at baseline and six months after the intervention. The educational intervention for the intervention group was implemented over four weeks, and the data were analyzed using SPSS software. The primary outcome was the change in the overall preventive lifestyle score. Participants in the intervention group had an average age of 42.81 (± 8.37) years and an average employment duration of 14.85 (± 8.79) years, while the control group had an average age of 41.72 (± 7.55) years and an average employment duration of 12.66 (± 8.34) years. The results showed that prior to and following the intervention, all participants (100%) in both groups were in the danger control process. After the intervention, there was a significant increase in the mean scores of perceived efficacy (p < 0.001), perceived response efficacy (p < 0.001), self-efficacy (p < 0.001), perceived severity (p < 0.001), fear (p < 0.001), intention (p < 0.001), and adoption of a preventive lifestyle for MetS (p < 0.001) in the intervention group compared to the control group. Following the intervention, the scores for defense mechanisms (p < 0.001), and perceived susceptibility (p < 0.001) significantly decreased in the intervention group compared to the control group. Following the intervention, the control group experienced a significant decrease in their attitude score compared to the intervention group (p < 0.001). Public health professionals should prioritize shifting individuals from the fear control process to the danger control process when designing educational interventions to prevent MetS. This approach should ensure that educational content emphasizes perceived efficacy and perceived threat to promote adaptive behavioral changes.Trial registration: Iranian Registry for Clinical Trial (the link to trial: https://www.irct.ir/trial/61288 ; IRCT registration number: IRCT20110727007132N21). Registered 02/02/2022. Prospectively registered.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.